ARCHIVES

FDA says new tools needed to speed therapeutics development.

This article is from The Cancer Letter archive.

Vol. 30 No. 13 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

Intramural Pis To Control Own Budgets, Have Greater Autonomy, Klausner Says

December 15, 1995

ACLU Sues Myriad, U.S. Patent Office Over Patents For BRCA Gene Mutations

May 15, 2009

DCT Advisors Approve Recompetition Of Drug Discovery Groups

June 23, 1995

In Brief: INTRA-NCI Scramble For Funds involves “Tricks, Machinations, Day To Day Battle”

July 16, 1976

Tumor Size Predicts Survival In Early-Stage Lung Cancer

November 28, 2003

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

September 25, 1998